Xeris Biopharma Holdings (XERS) Price to Sales (2021 - 2026)
Xeris Biopharma Holdings' Price to Sales came in at 4.10 for Q2 2026, up 33.9% from 3.06 a year earlier and up 28.9% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Price to Sales (2021 - 2026) Analysis & Trends
For FY2025, Xeris Biopharma Holdings' Price to Sales was 4.47, up 79.2% from FY2024.
- Price to Sales has increased in each of the last three years.
- Going back by year, Price to Sales was 2.49 in FY2024 (+26.0%), 1.98 in FY2023 (+20.5%), 1.64 in FY2022 (-64.8%) and 4.67 in FY2021 (-54.5%).
- The five-year range for quarterly Price to Sales is 1.64 (Q4 2022) to 5.47 (Q1 2022).
- Year-over-year, Price to Sales increased in seven of the last eight quarters, with growth averaging 55.9%.
- The fastest year-over-year change in Price to Sales over five years came in Q3 2025 (growth of 123.4%), and the weakest in Q2 2022 (a decline of 67.2%).
- Business Quant data shows XERS's Price to Sales at 3.18 (Q1 2026), 4.47 (Q4 2025) and 5.06 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.74 |
| Jun 30, 2026 | 4.10 |
| Mar 31, 2026 | 3.18 |
| Dec 31, 2025 | 4.47 |
| Sep 30, 2025 | 5.06 |
| Jun 30, 2025 | 3.06 |
| Mar 31, 2025 | 3.85 |
| Dec 31, 2024 | 2.49 |
| Sep 30, 2024 | 2.27 |
| Jun 30, 2024 | 1.85 |
| Mar 31, 2024 | 1.91 |
| Dec 31, 2023 | 1.98 |
| Sep 30, 2023 | 1.68 |
| Jun 30, 2023 | 2.70 |
| Mar 31, 2023 | 1.84 |
| Dec 31, 2022 | 1.64 |
| Sep 30, 2022 | 2.15 |
| Jun 30, 2022 | 2.62 |
| Mar 31, 2022 | 5.47 |
| Dec 31, 2021 | 4.67 |
API Access
Xeris Biopharma Holdings Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();